These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3882481)

  • 1. Receptor-mediated degradation and internalization of insulin in the adenocarcinoma cell line HT-29 from human colon.
    Sonne O
    Mol Cell Endocrinol; 1985 Jan; 39(1):39-48. PubMed ID: 3882481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of receptor-mediated degradation of insulin in isolated rat adipocytes: indirect evidence for a non-lysosomal pathway.
    Sonne O; Gliemann J
    Mol Cell Endocrinol; 1983 Aug; 31(2-3):315-31. PubMed ID: 6138287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-mediated degradation of human growth hormone in rat adipocytes and cultured human lymphocytes (IM-9).
    Weyer B; Sonne O
    Mol Cell Endocrinol; 1985 Jun; 41(1):85-92. PubMed ID: 2989040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal degradation of receptor-bound 125I-labeled insulin by rat adipocytes: its characterization and dissociation from the short-term biologic effects of insulin.
    Hammons GT; Jarett L
    Diabetes; 1980 Jun; 29(6):475-86. PubMed ID: 6991335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
    Sonne O
    Biochim Biophys Acta; 1987 Jan; 927(1):106-11. PubMed ID: 3539208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of the lack of receptor-mediated insulin degradation in human cultured lymphocytes (RPMI-1788 line).
    Maegawa H; Kobayashi M; Ohgaku S; Yasuda H; Iwasaki M; Watanabe N; Shigeta Y
    Endocrinol Jpn; 1983 Oct; 30(5):679-87. PubMed ID: 6368212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
    Ward WF; Moss AL
    Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.
    Furlanetto RW
    Endocrinology; 1988 May; 122(5):2044-53. PubMed ID: 2966062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymotrypsin substrate analogues inhibit endocytosis of insulin and insulin receptors in adipocytes.
    Jochen AL; Berhanu P
    J Cell Biol; 1986 Nov; 103(5):1807-16. PubMed ID: 2877995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated endocytosis of insulin in lower vertebrates: internalization and intracellular processing of 125I-insulin in isolated hepatocytes of lamprey and frog.
    Lappova YL; Leibush BN
    Gen Comp Endocrinol; 1995 Oct; 100(1):1-9. PubMed ID: 8575649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin binding, internalization, and receptor regulation in cultured human fibroblasts.
    Baldwin D; Prince M; Tsai P; Johnson C; Lotan R; Rubenstein AH; Olefsky JM
    Am J Physiol; 1981 Sep; 241(3):E251-60. PubMed ID: 7025657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-linked degradation of 125I-insulin is mediated by internalization in isolated rat hepatocytes.
    Gorden P; Freychet P; Carpentier JL; Canivet B; Orci L
    Yale J Biol Med; 1982; 55(2):101-12. PubMed ID: 6753361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal and non-lysosomal pathways of intracellular insulin degradation in isolated rat hepatocytes.
    Draznin B; Todd WW; Leitner JW; Toothaker DR
    Horm Res; 1981; 15(4):252-62. PubMed ID: 6765590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptors: binding kinetics and structure-function relationship of insulin.
    Gammeltoft S
    Physiol Rev; 1984 Oct; 64(4):1321-78. PubMed ID: 6387730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of insulin by human fibroblasts: effects of inhibitors of pinocytosis and lysosomal activity.
    Kooistra T; Lloyd JB
    Int J Biochem; 1985; 17(7):805-11. PubMed ID: 3902530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of insulin by isolated mouse pancreatic acini. Evidence for cell surface protease activity.
    Goldfine ID; Williams JA; Bailey AC; Wong KY; Iwamoto Y; Yokono K; Baba S; Roth RA
    Diabetes; 1984 Jan; 33(1):64-72. PubMed ID: 6360769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor internalization and recycling: mechanism and significance.
    Carpentier JL; Fehlmann M; Van Obberghen E; Gorden P; Orci L
    Biochimie; 1985; 67(10-11):1143-5. PubMed ID: 3907718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.